Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
Aims Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
[PDF][PDF] Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
G Filippatos, SD Anker, P August… - European Heart …, 2023 - academic.oup.com
Aims Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
G Filippatos, SD Anker, P August… - European heart …, 2023 - pubmed.ncbi.nlm.nih.gov
Aims Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
G Filippatos, SD Anker, P August, AJS Coats… - European Heart …, 2023 - ppm.edu.pl
Abstract in original language Aims: Finerenone reduces the risk of cardiovascular events in
patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We investigated the …
patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We investigated the …
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
G Filippatos, SD Anker, P August… - European heart …, 2023 - research.regionh.dk
AIMS: Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.
G Filippatos, SD Anker, P August… - European Heart …, 2023 - europepmc.org
Aims Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
G Filippatos, SD Anker, P August… - European Heart …, 2023 - search.proquest.com
Aims Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
[HTML][HTML] Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
G Filippatos, SD Anker, P August… - European Heart …, 2023 - ncbi.nlm.nih.gov
Aims Finerenone reduces the risk of cardiovascular events in patients with chronic kidney
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
disease (CKD) and type 2 diabetes (T2D). We investigated the causes of mortality in the …
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
G Filippatos, SD Anker, P August, AJS Coats… - European Heart …, 2023 - ppm.edu.pl
Streszczenie w języku oryginału Aims: Finerenone reduces the risk of cardiovascular events
in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We investigated …
in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We investigated …